Patent · US Active

Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist

US10981967B2 · kind B2 · utility

1Cited by
6References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2019
Grant dateApr 20, 2021
Priority date—
Expiry dateJan 31, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A long-acting conjugate of a triple agonist which has activities to all of glucagon, GLP-1, and GIP receptors and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.